文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

脑胶质瘤的定量磁敏感图评价。

Quantitative susceptibility mapping evaluation of glioma.

机构信息

Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, No. 58 Zhongshan Road 2, Guangdong, 510080, Guangzhou, People's Republic of China.

Department of MR Scientific Marketing, Siemens Healthineers, Guangzhou, Guangdong, People's Republic of China.

出版信息

Eur Radiol. 2023 Oct;33(10):6636-6647. doi: 10.1007/s00330-023-09647-4. Epub 2023 Apr 25.


DOI:10.1007/s00330-023-09647-4
PMID:37095360
Abstract

OBJECTIVES: To comprehensively evaluate the glioma using quantitative susceptibility mapping (QSM). MATERIALS AND METHODS: Forty-two patients (18 women; mean age, 45 years) with pathologically confirmed gliomas were retrospectively included. All the patients underwent conventional and advanced MRI examinations (QSM, DWI, MRS, etc.). Five patients underwent paired QSM (pre- and post-enhancement). Four Visually Accessible Rembrandt Image (VASARI) features and intratumoural susceptibility signal (ITSS) were observed. Three ROIs each were manually drawn separately in the tumour parenchyma with relatively high and low magnetic susceptibility. The association between the tumour's magnetic susceptibility and other MRI parameters was also analysed. RESULTS: Morphologically, gliomas with heterogeneous ITSS were more similar to high-grade gliomas (p = 0.006, AUC: 0.72, sensitivity: 70%, and specificity: 73%). Heterogeneous ITSS was significantly associated with tumour haemorrhage, necrosis, diffusion restriction, and avid enhancement but did not change between pre- and post-enhanced QSM. Quantitatively, tumour parenchyma magnetic susceptibility had limited value in grading gliomas and identifying IDH mutation status, whereas the relatively low magnetic susceptibility of the tumour parenchyma helped identify oligodendrogliomas in IDH mutated gliomas (AUC = 0.78) with high specificity (100%). The relatively high tumour magnetic susceptibility significantly increased after enhancement (p = 0.039). Additionally, we found that the magnetic susceptibility of the tumour parenchyma was significantly correlated with ADC (r = 0.61) and Cho/NAA (r = 0.40). CONCLUSIONS: QSM is a promising candidate for the comprehensive evaluation of gliomas, except for IDH mutation status. The magnetic susceptibility of tumour parenchyma may be affected by tumour cell proliferation. KEY POINTS: • Morphologically, gliomas with a heterogeneous intratumoural susceptibility signal (ITSS) are more similar to high-grade gliomas (p = 0.006; AUC, 0.72; sensitivity, 70%; and specificity, 73%). Heterogeneous ITSS was significantly associated with tumour haemorrhage, necrosis, diffusion restriction, and avid enhancement but did not change between pre- and post-enhanced QSM. • Tumour parenchyma's relatively low magnetic susceptibility helped identify oligodendroglioma with high specificity. • Tumour parenchyma magnetic susceptibility was significantly correlated with ADC (r = 0.61) and Cho/NAA (r = 0.40).

摘要

目的:全面评估脑胶质瘤的情况,使用定量磁化率映射(QSM)技术。

材料与方法:回顾性纳入 42 例经病理证实的脑胶质瘤患者(18 名女性;平均年龄 45 岁)。所有患者均接受了常规和高级 MRI 检查(QSM、DWI、MRS 等)。5 例患者进行了配对 QSM(增强前后)检查。观察了 4 种 Visually Accessible Rembrandt Image(VASARI)特征和肿瘤内磁化率信号(ITSS)。在肿瘤实质内相对高和低磁化率的部位分别手动绘制了 3 个 ROI。还分析了肿瘤的磁化率与其他 MRI 参数之间的相关性。

结果:形态学上,具有不均匀 ITSS 的脑胶质瘤更类似于高级别胶质瘤(p=0.006,AUC:0.72,敏感性:70%,特异性:73%)。不均匀 ITSS 与肿瘤出血、坏死、弥散受限和强化明显相关,但在增强前后的 QSM 中没有变化。定量方面,肿瘤实质的磁化率在胶质瘤分级和 IDH 突变状态的鉴别中价值有限,而肿瘤实质的相对低磁化率有助于在 IDH 突变的脑胶质瘤中识别少突胶质细胞瘤(AUC=0.78,特异性为 100%)。增强后肿瘤实质的相对高磁化率显著增加(p=0.039)。此外,我们发现肿瘤实质的磁化率与 ADC(r=0.61)和 Cho/NAA(r=0.40)显著相关。

结论:除了 IDH 突变状态外,QSM 是一种很有前途的脑胶质瘤综合评估方法。肿瘤实质的磁化率可能受肿瘤细胞增殖的影响。

相似文献

[1]
Quantitative susceptibility mapping evaluation of glioma.

Eur Radiol. 2023-10

[2]
Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading.

Acta Radiol. 2019-6

[3]
Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.

Eur J Radiol. 2010-8-13

[4]
Comparative analysis of the diffusion kurtosis imaging and diffusion tensor imaging in grading gliomas, predicting tumour cell proliferation and IDH-1 gene mutation status.

J Neurooncol. 2018-11-9

[5]
Investigated diagnostic value of synthetic relaxometry, three-dimensional pseudo-continuous arterial spin labelling and diffusion-weighted imaging in the grading of glioma.

Magn Reson Imaging. 2022-2

[6]
Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.

Eur Radiol. 2019-12-11

[7]
Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas.

Acta Radiol. 2021-12

[8]
Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.

J Magn Reson Imaging. 2022-12

[9]
Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.

Cancer Imaging. 2015-3-21

[10]
Quantitative analysis of neurite orientation dispersion and density imaging in grading gliomas and detecting gene mutation status.

Neuroimage Clin. 2018-4-12

引用本文的文献

[1]
Increased cortical iron deposition in glioma patients: a quantitative susceptibility mapping study.

J Neurooncol. 2025-4-16

[2]
Intra-tumoral susceptibility signals in brain gliomas: where do we stand?

Front Radiol. 2025-2-20

[3]
Predictive machine learning models based on VASARI features for WHO grading, isocitrate dehydrogenase mutation, and 1p19q co-deletion status: a multicenter study.

Am J Cancer Res. 2024-8-25

[4]
An update on susceptibility-weighted imaging in brain gliomas.

Eur Radiol. 2024-10

[5]
Histogram analysis of quantitative susceptibility mapping and apparent diffusion coefficient for identifying isocitrate dehydrogenase genotypes and tumor subtypes of adult-type diffuse gliomas.

Quant Imaging Med Surg. 2023-12-1

本文引用的文献

[1]
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.

Neuro Oncol. 2023-1-5

[2]
Brain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform in detecting this process?

Insights Imaging. 2022-4-13

[3]
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

Neuro Oncol. 2021-8-2

[4]
Multiecho complex total field inversion method (mcTFI) for improved signal modeling in quantitative susceptibility mapping.

Magn Reson Med. 2021-10

[5]
Adaptive Changes Allow Targeting of Ferroptosis for Glioma Treatment.

Cell Mol Neurobiol. 2022-10

[6]
Systematic Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in Neurodegenerative Diseases.

Front Neurosci. 2021-2-18

[7]
Diffusion kurtosis imaging in evaluating gliomas: different region of interest selection methods on time efficiency, measurement repeatability, and diagnostic ability.

Eur Radiol. 2021-2

[8]
Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.

Front Immunol. 2020

[9]
Iron leakage owing to blood-brain barrier disruption in small vessel disease CADASIL.

Neurology. 2020-6-25

[10]
Imaging of intratumoral heterogeneity in high-grade glioma.

Cancer Lett. 2020-2-27

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索